Funds raised will go to vital drug development research

There is currently no cure for neuroblastoma patients – but there is clear potential to develop one. A promising new combination drug, CBL0137 and HDAC  is showing definite progress, however urgent funding is required to accelerate the progress of these new drugs.

Professor Murray Norris, Deputy Director and Dr Toby Trahair, Clinical Doctor at the Childrens Cancer Institute talk about the vital research still needed to find a cure for childhood cancer neuroblastoma.